IWC
UNCY icon

Integrated Wealth Concepts’s Unicycive Therapeutics UNCY Stock Holding History

Integrated Wealth Concepts’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.69K Buy
+1,000
New +$7.38K ﹤0.01% 5002
2024
Q2 		– Sell
-1,000
Closed -$13.8K – 1715
2024
Q1 		$13.8K Hold
1,000
– – ﹤0.01% 1640
2023
Q4 		$8.68K Buy
+1,000
New +$6.54K ﹤0.01% 1586

Other funds holding UNCY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Integrated Wealth Concepts's UNCY Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Unicycive Therapeutics (UNCY) in Q2 2026: 1,000 shares worth $4.69K. The stake represents ﹤0.01% of the portfolio and ranks #5002 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in UNCY as recently as Q1 2024.

Integrated Wealth Concepts first reported a position in UNCY in Q4 2023 and has held it in 3 quarters since. The position peaked at $13.8K in Q1 2024. 80 funds tracked by Wall St. Rank hold UNCY as of Q2 2026.

  • Integrated Wealth Concepts held 1,000 shares of Unicycive Therapeutics worth $4.69K as of Q2 2026.
  • Unicycive Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Unicycive Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5002 holding.
  • Integrated Wealth Concepts first reported a position in Unicycive Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • Integrated Wealth Concepts's Unicycive Therapeutics position peaked at $13.8K in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.